✦ LIBER ✦

Myb targeted therapeutics for the treatment of human malignancies

✍ Scribed by Gewirtz, Alan M

Book ID: 110062203
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 156 KB
Volume: 18
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1202785

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting XIAP for the treatment of mali

Targeting XIAP for the treatment of malignancy

✍ Schimmer, A D; Dalili, S; Batey, R A; Riedl, S J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB

Therapeutic potential of the dual-target

Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies

✍ Olaf H. Temmink; Tomohiro Emura; Michiel De Bruin; Masakazu Fukushima; Godefridu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Vascular targeting therapies for treatme

Vascular targeting therapies for treatment of malignant disease

✍ Stephen L. Brown; Andrew Kolozsvary; Jae Ho Kim 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Vascular-targeting therapies for treatme

Vascular-targeting therapies for treatment of malignant disease

✍ Dietmar W. Siemann; David J. Chaplin; Michael R. Horsman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

## Abstract ## BACKGROUND Tumor endothelium represents a valuable target for cancer therapy. The vasculature plays a critical role in the survival and continued growth of solid tumor masses; in addition, the inherent differences between tumor blood vessels and blood vessels associated with normal

Targeting AMPK in the treatment of malig

Targeting AMPK in the treatment of malignancies

✍ Eliza Vakana; Jessica K. Altman; Leonidas C. Platanias 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

## Abstract The AMPK pathway is a metabolic stress‐related and energy censor pathway which plays important regulatory roles in normal and malignant cells. This cellular cascade controls generation of signals for initiation of mRNA translation via the mTOR pathway and exhibits regulatory roles on th

New therapeutic targets for the treatmen

New therapeutic targets for the treatment of high-risk neuroblastoma

✍ Lars M. Wagner; Mary K. Danks 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract High‐risk neuroblastoma remains a major problem in pediatric oncology, accounting for 15% of childhood cancer deaths. Although incremental improvements in outcome have been achieved with the intensification of conventional chemotherapy agents and the addition of 13‐__cis__‐retinoic acid